RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/9058810http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/9058810http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/9058810http://www.w3.org/2000/01/rdf-schema#comment"It is well established that target cell lysis by MHC class I-restricted CD8+ T cells is an important defense mechanism during infections with intracellular pathogens or against tumor targets. On the other hand, little is known about the physiologic role and the mechanisms of cytotoxicity of CD4+ MHC class II-restricted T cells. We have recently demonstrated that human autoreactive CD4+ T cells specific for one candidate autoantigen of multiple sclerosis, myelin basic protein, can mediate cytotoxicity. In the present report, we analyze the cytolytic mechanisms employed by these cells. We show that individual T cell clones, regardless of their cytokine phenotype, can be noncytotoxic or lyse target cells via either perforin- or Fas/Fas ligand-mediated cytotoxicity."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Martin R."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Martin R."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Biddison W.E."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Biddison W.E."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Hemmer B."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Hemmer B."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"McFarland H.F."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"McFarland H.F."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Muraro P.A."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Muraro P.A."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Sarin A."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Sarin A."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Tranquill L."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Tranquill L."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Vergelli M."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/author"Vergelli M."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/date"1997"xsd:gYear
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/date"1997"xsd:gYear
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/name"J. Immunol."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/name"J. Immunol."xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/pages"2756-2761"xsd:string
http://purl.uniprot.org/citations/9058810http://purl.uniprot.org/core/pages"2756-2761"xsd:string